Navigation Links
'Comb on a chip' powers new NIST/Caltech atomic clock design
Date:7/22/2014

limeter-wide silica disk that generates the frequency comb for the new clock.

The new microcomb clock uses a laser to excite the Caltech disk to generate a frequency comb, broadens the spectrum using nonlinear fiber, and stabilizes two comb teeth (individual frequencies) to energy transitions in rubidium atoms that "tick" at optical frequencies. (Conventional rubidium atomic clocks operate at much lower microwave frequencies.) The comb converts these optical frequency ticks to the microwave domain.

Thanks to the gear-like properties of the disk and the comb, the output is also 100 times more stable than the intrinsic ticking of the rubidium atoms. According to Diddams. "A simple analogy is that of a mechanical clock: The rubidium atoms provide stable oscillationsa pendulumand the microcomb is like a set of gears that synthesizes optical and microwave frequencies."

The center of the comb spectrum is locked to an infrared laser operating at 1560 nanometers, a wavelength used in telecommunications.

NIST researchers have not yet systematically analyzed the microcomb clock's precision. The prototype uses a tabletop-sized rubidium reference. The scientists expect to reduce the instrument size by switching to a miniature container of atoms like that used in NIST's original chip-scale atomic clock.*** Scientists also hope to find a more stable atomic reference.

The microcomb chip was made by use of conventional semiconductor fabrication techniques and, therefore, could be mass produced and integrated with other chip-scale components such as lasers and atomic references. NIST researchers expect that, with further research, the microcomb clock architecture can achieve substantially better performance in the future.


'/>"/>

Contact: Laura Ost
laura.ost@nist.gov
303-497-4880
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
2. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
3. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
4. Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging
5. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
6. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
7. New nano-material combinations produce leap in infrared technology
8. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
9. Honeycombs of magnets could lead to new type of computer processing
10. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
11. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Comb on a chip' powers new NIST/Caltech atomic clock design
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... 2015 , ... The 2015 Market Research Report on the Global Propanol ... global Propanol market with a focus on the Chinese situation. Major companies included in ... ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The ...
(Date:7/30/2015)... KANSAS CITY, Kan. , July 30, 2015 ... PETX ), a pet therapeutics company focused on ... products for companion animals, today announced that its ... results from a dose confirmation study of AT-016, ... to Aratana for the treatment of osteoarthritis pain ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Larry Bossidy have been lionized in the press and ... bottom line performance and stellar financial results. While these ... lessons, the management philosophies they represent and the practices ... Jacks rank and yank approach to pruning the bottom ...
... impressions. And I have to admit that when my former ... issue of DEMOletter, I was rather dismissive. After all, the ... were imploding left and right and I was certain that ... long. , ,I couldn't have been more wrong. More than two ...
... Aurora Health Care , based in Milwaukee, will become ... eICU technology to its critical-care patients. The eICU solution ... to connect and provide off-site critical care physicians and ... patients. , ,Baltimore-based Visicu Inc. developed ...
Cached Biology Technology:Seven leadership lessons of Next Generation Companies 2Seven leadership lessons of Next Generation Companies 3Confoti: Revisiting a dotcom business model 2Confoti: Revisiting a dotcom business model 3Confoti: Revisiting a dotcom business model 4Confoti: Revisiting a dotcom business model 5
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... FRANKLIN LAKES , N.J. and NEW YORK ... and Company) and Guidepoint today announced ... selected start-up healthcare companies with free access to Guidepoint,s ... mentoring several start-ups that are developing cutting-edge technologies to ... of a dedicated Guidepoint research manager, each start-up entrepreneur ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... of Copenhagen have agreed to set up a ... resources can benefit the country. Greenland,s premier, Kuupik ... support the initiative. The committee will examine ... how they can create value for Greenland through, ...
... A South Dakota School of Mines & Technology ... species of herbivorous dinosaur and published the first fossil ... Research by Clint Boyd, Ph.D., provides the first definitive ... of choice for the crocodyliform, a now extinct relative ...
... of hundreds of thousands of individuals (known as Genome-wide ... regions in the genome to the risk of developing ... (EMBL) and the University of Heidelberg, through the joint ... one step further by pinpointing the exact genes that ...
Cached Biology News:Experts to calculate potential of Greenlandic mineral wealth 2Research unearths new dinosaur species 2Research unearths new dinosaur species 3Zeroing in on heart disease 2
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
...
... with Annexin V-FITC to distinguish cells that ... (Annexin V positive, PI negative) from those ... or already dead (Annexin V-FITC positive, PI ... range of the spectrum using a 562-588 ...
... Mouse A-20 cells were cultured in RPMI ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Biology Products: